Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
NCT ID: NCT00893490
Last Updated: 2009-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma
NCT00371072
Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma, Superior Versus Inferior
NCT00628173
AGV Implantation With Ologen in Pediatric Glaucomas
NCT05014386
Intraluminal Stenting Versus External Ligation of Ahmed Glaucoma Valve
NCT04508881
Ahmed Glaucoma Valve Implantation; Graft-Free Short Tunnel Small Flap Versus Scleral Patch Graft
NCT03551834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ahmed Glaucoma Valve (AGV) alone
Ahmed Glaucoma Valve (AGV)
AGV implantation
AGV plus MMC
Ahmed Glaucoma Valve (AGV)
AGV implantation
Mitomycin C (MMC)
3 minute MMC application
AGV plus amniotic membrane coverage
Ahmed Glaucoma Valve (AGV)
AGV implantation
amniotic membrane coverage
single layer coverage of amniotic membrane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ahmed Glaucoma Valve (AGV)
AGV implantation
Mitomycin C (MMC)
3 minute MMC application
amniotic membrane coverage
single layer coverage of amniotic membrane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* adults above 75 years old
* uncooperative patients
* patients underwent the operation for second time
* patients with major operation with AGV
7 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ophthalmic Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ophthalmic Research Center
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8756
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.